These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15504096)

  • 41. Overview of brachytherapy resources in Europe: a survey of patterns of care study for brachytherapy in Europe.
    Guedea F; Ellison T; Venselaar J; Borras JM; Hoskin P; Poetter R; Heeren G; Nisin R; François G; Mazeron JJ; Limbergen EV; Ventura M; Taillet M; Cottier B
    Radiother Oncol; 2007 Jan; 82(1):50-4. PubMed ID: 17150270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bioethics and pharmacoeconomics: a difficult balance].
    Felicetti V; Cristina G; Cifaldi L
    Clin Ter; 2008; 159(1):29-32. PubMed ID: 18399259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The need for guidelines and the use of economic evidence in decision-making in Thailand: lessons learnt from the development of the national list of essential drugs.
    Wibulpolprasert S;
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S1-3. PubMed ID: 19255984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishing a national clearinghouse on international medical education programs: an idea whose time has finally come.
    Johnson DA
    Acad Med; 2008 Mar; 83(3):305-8. PubMed ID: 18316883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccines and Internet: characteristics of the vaccine safety net web sites and suggested improvements.
    Martínez-Mora M; Alvarez-Pasquín MJ; Rodríguez-Salvanés F
    Vaccine; 2008 Dec; 26(52):6950-5. PubMed ID: 18951940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Access to electronic health knowledge in five countries in Africa: a descriptive study.
    Smith H; Bukirwa H; Mukasa O; Snell P; Adeh-Nsoh S; Mbuyita S; Honorati M; Orji B; Garner P
    BMC Health Serv Res; 2007 May; 7():72. PubMed ID: 17509132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health and medical news on the Web: comparing the results of news-providing Web resources.
    Cunningham K
    Med Ref Serv Q; 2005; 24(4):17-40. PubMed ID: 16203699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Educational standards of the Polish Pharmacoeconomic Society].
    Czech M; Hermanowski T; Kocić I; Lis J; Nowakowska E;
    Pol Merkur Lekarski; 2009 Nov; 27(161):400-3. PubMed ID: 19999805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and evolution of The Knowledge Hub for Pathology and related electronic resources.
    Hardwick DF; Sinard J; Silva F
    Hum Pathol; 2011 Jun; 42(6):795-801. PubMed ID: 21316077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of pharmacoeconomics analyses to health protection].
    Drozd M
    Wiad Lek; 2002; 55 Suppl 1():76-9. PubMed ID: 15002222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pharmacoeconomics as a tool for the synthesis of available information on drugs].
    Taboulet F; Béresniak A
    Therapie; 2000; 55(1):119-22. PubMed ID: 10860011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What is next for pharmacoeconomics and outcomes research in Asia?
    Doherty J; Kamae I; Lee KK; Li H; Li SC; Liu GG; Tarn YH; Yang BM
    Value Health; 2004; 7(2):118-32. PubMed ID: 15164802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.
    Alzarea AI; Khan YH; Alanazi AS; Butt MH; Almalki ZS; AlAhmari AK; Alsahali S; Mallhi TH
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Considerations in the pharmacoeconomics of glaucoma.
    Hirsch JD
    Manag Care; 2002 Nov; 11(11 Suppl):32-7. PubMed ID: 15357537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overview of pharmacoeconomics and pharmaceutical outcomes evaluations.
    Reeder CE
    Am J Health Syst Pharm; 1995 Oct; 52(19 Suppl 4):S5-8. PubMed ID: 8846244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries.
    Eljilany I; El-Dahiyat F; Curley LE; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):403-414. PubMed ID: 29779401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Barriers to implementing pharmacoeconomics: interview study.
    Alefan Q; Hamdouni E; Alhamad H; Mukattash T; Rascati K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):93-104. PubMed ID: 32394752
    [No Abstract]   [Full Text] [Related]  

  • 58. Emerging role of pharmacoeconomics in the research and development decision-making process.
    DiMasi JA; Caglarcan E; Wood-Armany M
    Pharmacoeconomics; 2001; 19(7):753-66. PubMed ID: 11548911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project.
    Deluca P; Davey Z; Corazza O; Di Furia L; Farre M; Flesland LH; Mannonen M; Majava A; Peltoniemi T; Pasinetti M; Pezzolesi C; Scherbaum N; Siemann H; Skutle A; Torrens M; van der Kreeft P; Iversen E; Schifano F
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):221-6. PubMed ID: 22841965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relevance of international studies to informed pharmacoeconomics and health policy decisions.
    Lyles A
    Clin Ther; 2010 Jan; 32(1):106-7. PubMed ID: 20171416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.